The Effects Of Globalization On Astrazeneca

The pharmaceutical industry is the part of the healthcare sector that deals with medications. The industry comprises different subfields pertaining to the development, production, and marketing of medications. The main goal of the pharmaceutical industry is to provide drugs that prevent infections, maintain health, and cure diseases. This industry directly affects the global population, so a number of international regulatory bodies to monitor things like drug safety, patents, quality, and pricing are in place for protection. They are the World Health Organization (or WHO) US Food and Drug Administration (or FDA) Medicines and Healthcare Products Regulatory Agency (or MHRA). This is industry like many others that have challenges in which
Backed by a strong research base and extensive manufacturing and commercial skills, they have provided innovative, effective medicines that make a real difference for patients all around the world and continue to expand. They target important areas of healthcare and always aim to be the first with new ideas and innovations in all areas. They want to create value medication for customers, shareholders, employees, and the communities in which they work with and for. There are many factors that can negatively affect AstraZeneca profit potential and future success. The effects of globalization on AstraZeneca are the pharmaceutical industry has taken advantage of the modern trend of globalization to increase their assets. This can cause AstraZeneca to want to spend large amounts of money on advertising, marketing and even lobbying government or parliament decision making government officials. Another major factor that can affect AstraZeneca government regulation. When government regulation is involved, they tend to lengthen the process for bringing new pharmaceuticals to market. Although some people see this as the government helping companies like AstraZeneca see this a challenge or blockage for future profits. This creates more completion, slower pipeline of products, higher expectations of consumer and this can threaten weather or not consumers will buy a product. This in return can create bad public
The biomedical, industrial complex has educated lots of young graduate students and postdocs over the past decade, during the boom in funding from the late-90s to the early 2000s. Many of these people are stuck with no job prospects, because they can’t get the precious few faculty gigs at cash-strapped universities, and most haven’t gotten all the training and mentoring they need to be relevant for jobs in industry. Another suggestion is to connect with a global partnership in the this sector. More preferred factories, supplier, together with simplified and standardized automation structures form the cornerstones of the strategy. The business trend I think the company should focus on is corporate social responsibility. CSR is defined, organizational structures for managing CSR, current CSR activities, and motivations for CSR. Primary factors that can motivate AstraZeneca CSR engagement are reputational benefits, recruitment and employee satisfaction, better rankings in sustainability indices, entrance into new markets, long-term economic returns, and improved population health. In terms of CSR strategy AstraZeneca needs to be at different points on a spectrum ranging from philanthropic donations to integrate systemic shared value business